These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36752824)

  • 21. Family functioning moderates the impact of psychosis-risk symptoms on social and role functioning.
    Thompson E; Rakhshan P; Pitts SC; Demro C; Millman ZB; Bussell K; DeVylder J; Kline E; Reeves GM; Schiffman J
    Schizophr Res; 2019 Feb; 204():337-342. PubMed ID: 30205908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and characterization of college students with attenuated psychosis syndrome in China.
    Chen F; Wang L; Heeramun-Aubeeluck A; Wang J; Shi J; Yuan J; Zhao X
    Psychiatry Res; 2014 May; 216(3):346-50. PubMed ID: 24636247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability of the Chinese version of the 16-item Prodromal Questionnaire (CPQ-16) for identifying attenuated psychosis syndrome in a college population.
    Chen F; Wang L; Wang J; Heeramun-Aubeeluck A; Yuan J; Zhao X
    Early Interv Psychiatry; 2016 Aug; 10(4):308-15. PubMed ID: 25113068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS.
    Woods SW; Parker S; Kerr MJ; Walsh BC; Wijtenburg SA; Prunier N; Nunez AR; Buccilli K; Mourgues-Codern C; Brummitt K; Kinney KS; Trankler C; Szacilo J; Colton BL; Ali M; Haidar A; Billah T; Huynh K; Ahmed U; Adery LL; Marcy PJ; Allott K; Amminger P; Arango C; Broome MR; Cadenhead KS; Chen EYH; Choi J; Conus P; Cornblatt BA; Glenthøj LB; Horton LE; Kambeitz J; Kapur T; Keshavan MS; Koutsouleris N; Langbein K; Lavoie S; Diaz-Caneja CM; Mathalon DH; Mittal VA; Nordentoft M; Pasternak O; Pearlson GD; Gaspar PA; Shah JL; Smesny S; Stone WS; Strauss GP; Wang J; Corcoran CM; Perkins DO; Schiffman J; Perez J; Mamah D; Ellman LM; Powers AR; Coleman MJ; Anticevic A; Fusar-Poli P; Kane JM; Kahn RS; McGorry PD; Bearden CE; Shenton ME; Nelson B; Calkins ME; Hendricks L; Bouix S; Addington J; McGlashan TH; Yung AR;
    Early Interv Psychiatry; 2024 Apr; 18(4):255-272. PubMed ID: 37641537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of clinical symptomatology in pediatric patients at clinical high risk for psychosis.
    Rintell LS; Carroll D; Wales M; Gonzalez-Heydrich J; D'Angelo E
    BMC Res Notes; 2024 Mar; 17(1):88. PubMed ID: 38532408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.
    Zhang T; Xu L; Tang Y; Cui H; Wei Y; Wang J; Tang X; Li C; Wang J
    Psychol Med; 2018 Jun; 48(8):1274-1281. PubMed ID: 29173206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.
    Hauke DJ; Schmidt A; Studerus E; Andreou C; Riecher-Rössler A; Radua J; Kambeitz J; Ruef A; Dwyer DB; Kambeitz-Ilankovic L; Lichtenstein T; Sanfelici R; Penzel N; Haas SS; Antonucci LA; Lalousis PA; Chisholm K; Schultze-Lutter F; Ruhrmann S; Hietala J; Brambilla P; Koutsouleris N; Meisenzahl E; Pantelis C; Rosen M; Salokangas RKR; Upthegrove R; Wood SJ; Borgwardt S;
    Transl Psychiatry; 2021 May; 11(1):312. PubMed ID: 34031362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
    Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
    J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Family history of psychosis in youth at clinical high risk: A replication study.
    Santesteban-Echarri O; Sandel D; Liu L; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Tsuang MT; Walker EF; Woods SW; Addington J
    Psychiatry Res; 2022 May; 311():114480. PubMed ID: 35245743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of a family history of psychosis for youth at clinical high risk of psychosis.
    Georgopoulos G; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):251-256. PubMed ID: 28792113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Violent Content in Attenuated Psychotic Symptoms.
    Marshall C; Deighton S; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon D; Addington J
    Psychiatry Res; 2016 Aug; 242():61-66. PubMed ID: 27259137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.
    Addington J; Liu L; Perkins DO; Carrion RE; Keefe RS; Woods SW
    Schizophr Bull; 2017 Jan; 43(1):57-63. PubMed ID: 27798225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adolescents and adults at clinical high-risk for psychosis: age-related differences in attenuated positive symptoms syndrome prevalence and entanglement with basic symptoms.
    Gerstenberg M; Theodoridou A; Traber-Walker N; Franscini M; Wotruba D; Metzler S; Müller M; Dvorsky D; Correll CU; Walitza S; Rössler W; Heekeren K
    Psychol Med; 2016 Apr; 46(5):1069-78. PubMed ID: 26671170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiety in youth at clinical high risk for psychosis.
    McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.
    Azis M; Strauss GP; Walker E; Revelle W; Zinbarg R; Mittal V
    Schizophr Bull; 2019 Sep; 45(5):1042-1050. PubMed ID: 30535399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.